Šalis: Izraelis
kalba: anglų
Šaltinis: Ministry of Health
GLUCOSE ANHYDROUS; SODIUM CHLORIDE
NEOPHARM (ISRAEL) 1996 LTD
B05BB01
SOLUTION FOR INJECTION
SODIUM CHLORIDE 0.18 G / 100 ML; GLUCOSE ANHYDROUS 4.3 G / 100 ML
I.V
Required
NEOPHARM (ISRAEL) LTD - CURE MEDICAL MANUFACTURING PLANT
ELECTROLYTES
ELECTROLYTES
Supply of water for administration of electrolytes or calories. Vehicle for therapeutic regimen.
2011-01-31
NEOPHARM (ISRAEL) LTD. - INTRAVENOUS INJECTIONS IN PLASTIC CONTAINERS 1. SINGLE ELECTROLYTE SOLUTIONS 1. 0.45% Sodium Chloride Injection. 2. SINGLE ELECTROLYTE SOLUTIONS WITH DEXTROSE 1. 3.3% Dextrose and 0.3% Sodium Chloride Injection. 2. 4.3% Dextrose and 0.18% Sodium Chloride Injection. 3. 5% Dextrose and 0.33% Sodium Chloride Injection. 4. 5% Dextrose and 0.45% Sodium Chloride Injection. 5. 5% Dextrose and 0.9% Sodium Chloride Injection. 3. MULTIPLE ELECTROLYTE SOLUTIONS WITH DEXTROSE 1. 5% Dextrose and 0.3% Sodium Chloride and 0.15% Potassium Chloride Injection. DESCRIPTION Intravenous solutions are sterile, nonpyrogenic and contain no bacteriostatic or antimicrobial agents or added buffers. The composition, osmolarity and approx. pH values of the individual solutions are shown in Table 1. ACTIONS Intravenous solutions provide electrolytes and/or calories, and are a source of water for hydration. All are capable of inducing diuresis depending on the clinical condition of the patient. Solutions containing dextrose provide calories. See Table 2 for calories per liter of the various solutions. Solutions which are di-electrolytic or polyelectrolytic have value in maintaining or replenishing electrolytes. See Table 2 for ionic concentrations. INDICATIONS Supply of water, for administration of electrolytes or calories. Vehicle for therapeutic regimen. CONTRAINDICATIONS Excess body water volume. Diabetic coma with excessively high blood sugar (solutions containing glucose). Hypovolaemia. Cardiac insufficiency. Edema, ascites ( cirrhosis related syndrome). WARNINGS Dispensing without a doctor's prescription is prohibited. The administration of Intravenous Injections can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congestive conditions, or pulmonary edema. The risk of serum dilution is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congestion with peripheral and pulmonary edema Perskaitykite visą dokumentą